Stock listing

VSTM Stock Price, News, Filings & Events — Verastem, Inc.

Selected listing: VSTM · BOATS · USD · US

This page tracks Verastem, Inc.'s VSTM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VSTM:BOATS. VSTM:BOATS is the stock-level entry point for investors researching Verastem, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Verastem, Inc. is a public company traded under the ticker VSTM in the American market. The company has a market capitalization of approximately $531.6 million. Verastem focuses on developing therapies for cancer treatment, aiming to improve patient outcomes.

VSTM:BOATSUSDUSUpdated September 11, 2026
Verastem, Inc. logo
Ticker
VSTM:BOATS
Asset type
Stock
Market cap
$662.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Verastem, Inc. VSTM:BOATS stock context

This page tracks Verastem, Inc.'s VSTM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VSTM:BOATS. VSTM:BOATS is the stock-level entry point for investors researching Verastem, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Verastem, Inc. is a public company traded under the ticker VSTM in the American market. The company has a market capitalization of approximately $531.6 million. Verastem focuses on developing therapies for cancer treatment, aiming to improve patient outcomes.

Latest news from Verastem, Inc.

All Verastem, Inc. news →

Verastem, Inc. earnings calls

Research Verastem, Inc.

Alternate listings